CLOSE X
GO

Tata India Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
24.78 -0.03(-0.12%) NAV as on 27 Mar 2024
-2.49 % 1 M
57.81 % 1 Y
19.92 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.26

As on 29 Feb, 2024
age-icon Age :

8 yrs 3 m

Since 28 12 ,2015
exit_load Exit Load :

0.25%

aum AUM :

872.21 Crs

lock_in Lock-in :

0.25% on or before 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

5.96

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Meeta Shetty

LATEST ASSET & PORTFOLIO ALLOCATION

as on Feb 29 ,2024
Others 4.10 %
Equity 95.90 %

TOP HOLDINGS

Sun Pharmaceutical Industries...14.28 %
Lupin Ltd.10.08 %
Aurobindo Pharma Ltd.8.44 %
Cipla Ltd.7.04 %
Dr. Reddy's Laboratories Ltd.5.34 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs77.87
Hospital & Healthcare Services13.50
Business Support3.33
Fertilizers0.74
Chemicals0.45
See All Sectors

5-YEARS HISTORY

Financial Year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 27-Mar-2024)8.9314.7317.1815.8824.78
Net Assets(Rs Crores) (as on 27-Mar-2024) 152.64 435.03 553.33 493.44 872.21
Scheme Returns(%)(Absolute)-2.1967.2416.04-7.3155.70
B'mark Returns(%)(Absolute)NANANANANA
Category Rank11/7549/7541/7567/7619/90

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity24.78-0.03(-0.12%)NAV As on 28 Mar, 202428-Dec-2015Inception Date872.21AUM In Cr.57.81%1Y19.92%3Y22.89%5Y11.62%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity339.992.24(0.66%)NAV As on 28 Mar, 202414-Jul-1999Inception Date2,608.30AUM In Cr.59.13%1Y21.47%3Y23.61%5Y16.10%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity29.87-0.02(-0.07%)NAV As on 28 Mar, 202413-Jul-2018Inception Date3,694.82AUM In Cr.61.98%1Y20.84%3Y24.48%5Y21.13%Since Inception
Nippon India Pharma Fund(G)Very HighEquity424.10-0.19(-0.05%)NAV As on 28 Mar, 202405-Jun-2004Inception Date7,131.66AUM In Cr.57.66%1Y20.29%3Y23.21%5Y20.81%Since Inception
DSP Healthcare Fund-Reg(G)Very HighEquity32.330.03(0.10%)NAV As on 28 Mar, 202430-Nov-2018Inception Date2,318.65AUM In Cr.54.54%1Y20.05%3Y25.97%5Y24.65%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity31.140.36(1.17%)NAV As on 28 Mar, 202402-Jul-2018Inception Date2,218.12AUM In Cr.56.73%1Y19.39%3Y24.17%5Y21.88%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors